Skip to main content

Table 1 Clinicopathological characteristics of stage I–III undifferentiated gastric adenocarcinoma in terms of histology type

From: Clinicopathological characteristics and outcomes in stage I–III mucinous gastric adenocarcinoma: a retrospective study at a single medical center

Parameters

MC (n = 54)

SRCC (n = 545)

PDC (n = 871)

P value

Age (years), mean ± SD

64.2 ± 10.7

58.4 ± 13.4

62.5 ± 13.8

<0.0001

 Median

66.0

59.0

65.0

 

Sex

   

<0.001

 Male

31 (57.4)

269 (49.4)

522 (59.9)

 

 Female

23 (42.6)

276 (50.6)

349 (40.1)

 

Tumor size (cm), mean ± SD

6.4 ± 3.9

4.3 ± 3.4

5.1 ± 3.2

<0.0001

 Median

5.5

3.5

4.5

 

Type of gastrectomy

   

0.006

 Total

16 (29.6)

133 (24.4)

282 (32.4)

 

 Subtotal

38 (70.4)

412 (75.6)

589 (67.6)

 

Extent of LN dissection

   

0.773

 <D2

21 (38.9)

187 (34.3)

308 (35.4)

 

 ≥D2

33 (61.1)

358 (65.7)

563 (64.6)

 

No. of LN retrieval, mean ± SD

27.3 ± 15.8

28.1 ± 15.3

27.7 ± 14.7

0.856

 Median

23.0

25.0

25.0

 

T status

   

<0.0001

 T1

2 (3.7)

163 (29.9)

101 (11.6)

 

 T2

9 (16.7)

56 (10.3)

74 (8.5)

 

 T3

3 (5.6)

19 (3.5)

24 (2.8)

 

 T4

40 (74.1)

307 (56.3)

672 (77.2)

 

LN status

    

 N0

13 (24.1)

251 (46.1)

244 (28.0)

<0.0001

 N1

11 (20.4)

59 (10.8)

119 (13.7)

 

 N2

12 (22.2)

66 (12.1)

56 (17.9)

 

 N3

18 (33.3)

169 (31.0)

352 (40.4)

 

Stage

   

<0.0001

 I

5 (9.3)

190 (34.9)

120 (13.8)

 

 II

10 (18.5)

94 (17.2)

170 (19.5)

 

 III

39 (72.2)

261 (47.9)

581 (66.7)

 

Positive margins (R1 resection)

8 (14.8)

59 (10.8)

95 (10.9)

0.662

Lymphatic invasiona

   

<0.0001

 No

21 (39.6)

288 (53.4)

315 (36.7)

 

 Yes

32 (60.4)

251 (46.6)

544 (63.3)

 

Vascular invasiona

   

0.005

 No

44 (83.0)

479 (89.2)

710 (82.9)

 

 Yes

9 (17.0)

58 (10.8)

146 (17.1)

 

Perineural invasiona

   

0.001

 No

27 (51.9)

294 (54.9)

380 (44.3)

 

 Yes

25 (48.1)

242 (45.1)

477 (55.7)

 

Complicationsb

12 (22.2)

61 (11.2)

136 (15.6)

0.016

 Surgery-related

10 (18.5)

49 (9.0)

99 (11.4)

0.064

  Leakage

5 (9.3)

26 (4.8)

46 (5.3)

 

  Intra-abdominal abscess

4 (7.4)

18 (3.3)

38 (4.4)

 

  Wound infection

1 (1.9)

5 (0.9)

22 (2.5)

 

  Bleeding

1 (1.9)

9 (1.7)

11 (1.3)

 

  Delayed gastric emptying

0

1(0.2)

6 (0.7)

 

  Others

1 (1.9)

3 (0.6)

4 (0.5)

 

 Surgery unrelated

3 (5.6)

19 (3.5)

59 (6.8)

0.031

  Pneumonia

1 (1.9)

2 (0.4)

15 (1.7)

 

  Cardiovascular event

1 (1.9)

5 (0.9)

7 (0.8)

 

  Sepsis

0

2 (0.4)

8 (0.9)

 

  Paralytic ileus

0

2 (0.4)

5 (0.6)

 

  Atelectasis

0

0

6 (0.7)

 

  Others

4 (7.4)

21 (3.9)

45 (5.2)

 

Hospital mortality

4 (7.4)

14 (2.6)

33 (3.8)

0.130

Chemotherapyc

38 (84.4)

285 (81.7)

553 (75.6)

0.047

  1. Figures are numbers with percentages in parentheses, unless otherwise stated
  2. LN lymph node, MC mucinous carcinoma, PDC poorly differentiated carcinoma, SD standard deviation, SRCC signet ring cell carcinoma
  3. aSome data were missing
  4. bNumber of patients with event
  5. cExcluding T1/T2N0 cases or hospital mortality